Amid Mixed Data, Teradyne (TER) is Still Cheap; Cowen Maintains 'Outperform'
Cowen & Company maintains its Outperform rating and $22 price target on Teradyne (NYSE: TER) following the company's fiscal Q413 ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
